Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sendurai A Mani

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Genome Biology|December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionGabriel G Malouf, Joseph H Taube, Yue Lu, et al.
Molecular Cancer Therapeutics|September 14, 2012
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancerAntonio Giordano, Hui Gao, Simone Anfossi, et al.
Plos One|July 25, 2015
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsEvan N Cohen, Hui Gao, Simone Anfossi, et al.
Cancer Research|January 24, 2025
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast CancerTanvi H Visal, Recep Bayraktar, Petra den Hollander, et al.
Cancer Research|February 5, 2013
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerBrett G Hollier, Agata A Tinnirello, Steven J Werden, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesJoseph H Taube, Jason I Herschkowitz, Kakajan Komurov, et al.
Immunity|August 1, 2025
Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cellsMarie Boutet, Kenta Nishitani, Nicole Couturier, et al.
Scientific Reports|September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesJoseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Heterogeneity and Plasticity|November 12, 2025
Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in CancerHans Clevers, Ankur Sharma, Sendurai A Mani, et al.
Eclinicalmedicine|March 5, 2026
Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trialsHsien-Chung Chen, Eric T Wong, Sasmit Sarangi, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Genome Biology|December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionGabriel G Malouf, Joseph H Taube, Yue Lu, et al.
Molecular Cancer Therapeutics|September 14, 2012
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancerAntonio Giordano, Hui Gao, Simone Anfossi, et al.
Plos One|July 25, 2015
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsEvan N Cohen, Hui Gao, Simone Anfossi, et al.
Cancer Research|January 24, 2025
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast CancerTanvi H Visal, Recep Bayraktar, Petra den Hollander, et al.
Cancer Research|February 5, 2013
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerBrett G Hollier, Agata A Tinnirello, Steven J Werden, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesJoseph H Taube, Jason I Herschkowitz, Kakajan Komurov, et al.
Immunity|August 1, 2025
Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cellsMarie Boutet, Kenta Nishitani, Nicole Couturier, et al.
Scientific Reports|September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesJoseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Heterogeneity and Plasticity|November 12, 2025
Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in CancerHans Clevers, Ankur Sharma, Sendurai A Mani, et al.
Eclinicalmedicine|March 5, 2026
Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trialsHsien-Chung Chen, Eric T Wong, Sasmit Sarangi, et al.
Pageof 11